at micromolar concentrations, induces significant functional changes in a wide variety of cells and tissues. ATP can be released from the cytosol of damaged cells or from exocytotic vesicles and/or granules contained in many types of secretory cells. There are also efficient extracellular mechanisms for the rapid metabolism of released nucleotides by ecto-ATPases and 5'-nucleotidases. The diverse biological responses to ATP are mediated by a variety of cell surface receptors that are activated when ATP or other nucleotides are bound. The functionally identified nucleotide or P,-purinergic receptors include 1) ATP receptors that stimulate G protein-coupled effector enzymes and signaling cascades, including inositol phospholipid hydrolysis and the mobilization of intracellular Ca 2+ stores; 2) ATP receptors that directly activate ligand-gated cation channels in the plasma membranes of many excitable cell types; 3) ATP receptors that, via the rapid induction of surface membrane channels and/or pores permeable to ions and endogenous metabolites, produce cytotoxic or activation responses in macrophages and other immune effector cells; and 4) ADP receptors that trigger rapid ion fluxes and aggregation responses in platelets. Current research in this area is directed toward the identification and structural characterization of these receptors by biochemical and molecular biological approaches.
play fundamental and ubiquitous roles in energy metabolism, nucleic acid synthesis, and enzyme regulation. There is now widespread appreciation that extracellular nucleotides and nucleosides also exert significant biological actions on many tissues and cells. In 1929, Drury and Szent-Gyorgyi (98) observed that extracellular ATP, then a newly identified and purified biomolecule, exerted profound effects on cardiovascular performance and other physiological functions. During the following half century, many pharmacological studies described the effects of extracellular adenine nucleotides on functional responses in various intact organ systems, isolated tissues, and purified cell preparations. In certain tissues, the responses were selectively induced by low concentrations of ATP per se. In other tissues, the biological responses to ATP were found to be absolutely dependent on catabolism of the extracellular nucleotide to adenosine. Given the results of extensive studies on neurotransmission, which was resistant to conventional adrenergic and choline@ antagonists, Burnstock (50, 51) suggested that ATP and/or adenosine, released at synaptic junctions, might mediate this "nonadrenergic noncholinergic" signaling.
He proposed that ATP might be released as a major neurotransmitter or as a cotransmitter from putative purinergic nerves. As a corollary to this model of purinergic neurotransmission, Burnstock also hypothesized that these nerves innervate target cells that express cell surface purinergic receptors (or purinoreceptors) for either ATP or its breakdown product adenosine. The putative ATP-selective receptors were termed P2-purinergic while the receptors for adenosine were called Pipurinergic. This nomenclature for adenosine receptors has been supplanted by the currently used terms Ai and A2 to denote the two major subtypes of adenosine receptor (reviewed in Refs. 48, 223) . The term P2-purinergic has persisted as a useful but imprecise (cf. Ref. 320) classification term for the various types (and subtypes) of ATP receptors.
Biological responses to extracellular ATP have been documented in virtually every major organ and/or tissue system that has been studied. Much of this information has been summarized in various reviews and symposium proceedings (cf. Refs. 15, 52, 56, 99, 103, 110, 154, 190, 258, 320, 345, 365, 367) . In this review, we hope to provide an overview of relatively recent developments in C578 INVITED REVIEW this field and to describe current perspectives on the classification of the various ATP receptors and ATPinduced biological responses. Studies on the biological actions of extracellular ATP constitute a significant body of literature that can be only partially cited in a short review. We recognize that many significant contributions have not been included in the list of cited references.
DIVERSITY OF THE BIOLOGICAL RESPONSES TO EXTRACELLULAR ADENINE NUCLEOTIDES
In considering the biological responses to extracellular ATP in multicellular tissues or organ systems, it is important to note that such effects are often complicated by 1) the presence of functionally distinct ATP receptor subtypes on the different cells that comprise the tissueorgan system and 2) the rapid catabolism of extracellular ATP to produce adenosine and the de facto stimulation of adenosine receptors. Thus exposure of many intact tissues/organs to extracellular ATP will produce complex multiphasic changes in the biological response, which includes contributions from both ATP receptor-based and adenosine receptor-based signal transduction in multiple cell types. Recent progress in characterization of adenosine receptor-based signaling and the synthesis of specific adenosine receptor antagonists has facilitated the identification of those organ-tissue-cell responses that can be unequivocally associated with the occupation of receptors for ATP rather than for adenosine. Some specific actions of ATP on certain organ systems or cell types are particularly noteworthy, given their potential physiological or pathological significance.
Cardiovascular System
By virtue of its ability to modulate contractility of most vascular smooth muscle types and cardiac myocytes, extracellular ATP can exert significant effects on cardiovascular function and regional blood flow (reviewed in Refs. 52, 56, 258, 270, and 365) . ATP induces multiphasic changes in both vasoconstriction and vasodilation in the vessels from many arterial and venous branches (reviewed in Refs. 52, 56, 367) . ATP-sensitive arteries include both capacitance vessels and resistance vessels. These constrictor effects appear to be associated primarily with direct stimulation of ATP receptors on the vascular smooth muscle cells per se (16, 17, 224, 274, 233, 365) . The effects of ATP on vascular smooth muscle ceils may be mediated by two major types of P,-purinergic receptors: I) those that directly act as ligand-gated cation channels (16, 17) and 2) those that indirectly regulate phospholipase-based signal transduction and the mobilization of 1,4,5-inositol trisphosphate [ Ins( 1,4,5)PJ -sensitive Ca2+ stores (224, 233, 249, 274, 351) .
ATP-dependent dilation or relaxation of intact blood vessels are primarily associated with the activation of ATP receptors that are expressed on most types of vascular endothelial cells (reviewed in Refs. 35, 36, 268) . These endothelial ATP receptors activate rapid mobilization of intracellular Ca2+ stores (161, 227, 228, 279) , and the increased cytosolic Ca2+ concentration ( [Ca2+]) is associated with the rapid release of several vasorelaxant agents, including prostacyclin (61, 62, 129, 228, 229, 268, 269) and nitric oxide (i.e., endothelium-derived relaxing factor, reviewed in Ref. 204) . Cultured endothelial cells have been extensively utilized for the detailed characterization of those ATP receptor types that activate phospholipase C (PLC) and phospholipase D (PLD)-based signal transduction reactions (89, 129, 228, 236, 279, 286) .
Extracellular ATP can also affect cardiac performance by directly modulating ionic currents, Ca2+ homeostasis, and excitation-contraction coupling in atrial and ventricular cardiomyocytes isolated from several species (5, 27, 69, 86, 90, 91, 135, 215, 284, 312, 313, 394, 395) . Cardiac muscle cells, like vascular smooth muscle cells, appear to express several functionally distinct types of ATP receptors including I) receptors that act as direct ligand-gated ion channels (135), and 2) receptors that indirectly modulate certain ionic exchangers (92, 284, 285) and second-messenger systems (215, 394, 395) . Certain chronotropic effects of ATP in intact rat hearts may involve the stimulation of ATP-gated ion channels that are expressed in neurons isolated from cardiac parasympathetic ganglia (120). Extracellular ATP in the cardiac perfusate can also accelerate sinus pacemaker activity, and this effect is correlated with a large increase in ATPstimulated prostanglandin synthesis (347) .
Nervous System
Functional responses to extracellular ATP have been identified in both neuronal (14, 105, 107, 115, 130, 136, 137, 139, 167, 181, 184, (207) (208) (209) (325) (326) (327) (328) 391) and glial cell types (230, 251, 253, 263, 275) .
Particularly salient is the ability of ATP to activate very rapid (millisecond time scale) depolarizing currents in several types of isolated neurons (14, 115, 120, 181, 184, (207) (208) (209) 326, 327) . Very recent studies have indicated that ATP may act as the predominant fast excitatory transmitter in certain pathways of synaptic transmission in both the central (CNS) and peripheral (PNS) nervous systems. ATP can mediate excitatory neurotransmission in cultured PNS neurons isolated from guinea pig celiac ganglia (115, 326, 327) and can act as a major excitatory transmitter in synaptic communication between CNS neurons of the rat medial habenula (105). Extracellular ATP attenuates acetylcholine release from frog preganglionic neurons (328) but potentiates spontaneous acetycholine release at the neuromuscular synapses that develop during in vitro culture of Xenopus-derived neurons and muscle cells (136). Exogenous ATP stimulates glutamate release from cultured hippocampal neurons, and the released glutamate, acting in an autocrine fashion, can stimulate rapid depolarizing currents (181).
The very rapid responses of neurons to ATP are most likely mediated by ATP receptors that act as ligand-gated ion channels (reviewed in Ref. 15) . Neuronal cell types also express ATP receptors that regulate, on a slower (seconds to minutes) time scale, second-messenger systems or ionic conductances that are generally associated with G protein-based signal transduction. These include the M current of certain sympathetic ganglion neurons (46) and the rapid hydrolysis of inositol phospholipids (139). The ATP receptors expressed in glial cells also INVITED REVIEW c579 modulate G proteins, ion channels, kinases, and other second-messenger-based signaling cascades (230, 251, 263, 275) .
Sensory Organs and/or Systems
Given the pronounced effects of extracellular ATP on some neuronal cell types, it is not surprising that ATP receptors have also been identified in sensory organs and/or cells, including the outer hair cells of guinea pig cochlea (9), the hair cells of chick cochlea (323) , and the olfactory cells of the lobster (60, 145). ATP-gated ion channel receptors have been identified on mammalian sensory neurons (207) (208) (209) . Fyffe and Per1 (137) have reported that ATP receptors may mediate mechanoreceptive input to certain spinal neurons from afferent fibers in mammalian skin.
Visceral Smooth Muscles and Skeletal Mzucle
In addition to activating contraction in vascular smooth muscle cells, extracellular ATP can stimulate contractile responses in visceral smooth muscles derived from diverse organ types (reviewed in Ref. 3lO), including vas deferens (104, 118, 134), urinary bladder (31, 183, 187), and myometrium (259). There is a massive literature (reviewed in Ref. 367 ) that indicates that ATP acts as a major cotransmitter (with norepinephrine) in mediating sympathetic regulation of contractile reponses in vas deferens and certain other smooth muscle-based organs. Patch-clamp electrophysiological studies have verified that ATP can activate receptors that act as ligandgated ion channels in single smooth muscle cells isolated from vas deferens (134), urinary bladder (179, 183, 315), and pregnant rat myometrium (172). Bo and Burnstock (32) and Bo et al. (33) have utilized membranes from bladder and vas deferens smooth muscle to identify (by radioligand-binding studies) and to solubilize an ATPbinding membrane protein that appears pharmacologically identical to P&ype purinergic receptors. (Nomenclature for the various types of ATP receptors is described in a subsequent section.) Ca2+-mobilizing ATP receptors that activate inositol phospholipid hydrolysis and various Ca2+-dependent ion channels have been identified in the DDTIMF-2 smooth muscle cell line that was derived from a leiomyosarcoma of hamster vas deferens (140, 169, 240) These ATP receptors that act as ligand-gated ion channels appear to be expressed in many types of cardiac and smooth muscle cells but not in adult skeletal muscle cells. However, ATP-gated ion channel receptors have been extensively characterized in embryonic myoblasts and myotubes (177, 206, 353, 354) .
Pulmonary System
Several important cell types in both the upper airways and in the lung are responsive to extracellular ATP. ATP can activate transepithelial Cl-secretion by epithelial cells isolated from the upper airways of normal human subjects or individuals with cystic fibrosis (70a, 237). Similar in situ responses have been observed when ATP is superfused over the nasal passages of either control subjects or patients with cystic fibrosis (203). ATP also increases the secretion of mucin from cultured airway goblet cells (195), and ATP greatly stimulates ciliary activity on epithelial cells from frog palate (378) . Tracheal smooth muscle responds to extracellular ATP with multiphasic changes in contractile state (70) . In the lung, ATP is a particularly efficacious agonist for stimulating surfactant release from type II alveolar pneumocytes (143, 293-295, 301, 372) .
At least some ATP-induced responses in respiratory cell types appear to be mediated by P2-purinergic receptors that activate inositol phospholipid hydrolysis and Ca2+ mobilization. These signaling events have been characterized in human airway epithelial cells (47, 237) and rat type II alveolar pneumocytes (293, 295) . In addition, exogenous ATP can increase the open probability of Cl-channels in patches excised from apical membrane of human airway epithelial cells (344) . This ATP-modulated conductance involves a mechanism that appears to be independent of second messengers and G proteins.
Inflammatory System
Ca2+-mobilizing ATP receptors have been identified in the neutrophils (11,79,212,214,369), monocytes (4,79), and macrophages (160,273) isolated from several species, including humans. Similar Ca2+-mobilizing ATP receptors are expressed in both normal (from bone marrow) and leukemic (from blood) human myeloid progenitor cells, including myeloblasts, promyelocytes, and promonocytes (79). Activation of these receptors in mature phagocytic leukocytes can either directly stimulate certain types of inflammatory responses or "prime" the effector cells for enhanced responsiveness to other inflammatory mediators. ATP (or ADP) can rapidly upregulate the surface expression of certain "adhesi& or integrintype receptors on the surface of human neutrophils (131) and monocytes (3,4). Upregulation of these surface molecules is associated with enhanced adhesion of circulating leukocytes to the endothelial surfaces and enhanced migration of the inflammatory cells into peripheral tissue spaces. ATP also acts as a secretagogue for enhanced exocytosis of primary granules from neutrophils and other phagocytic cell types (73, 74, 343, 388) In contrast, ATP per se does not activate superoxide release by human neutrophils. However, neutrophils pretreated with ATP or other nucleotide receptor agonists respond to formylated chemotactic peptides with a much-enhanced release of the bacteriocidal superoxide radicals (11, 212, 213, 319, 321, 369, 373) . ATP-induced priming also potentiates superoxide release from rat alveolar macrophages stimulated with immune complexes (160). In contrast to neutrophils, guinea pig peritoneal macrophages will respond to ATP per se with a significant release of superoxide (245).
Phagocytic leukocytes, like endothelial cells, have been widely utilized for detailed characterization of signal transduction pathways that are regulated by Ca2+-mobilizing ATP receptors. Several groups have studied the role of pertussis toxin-sensitive G proteins in mediating the effects of ATP receptor agonists on inositol phospholipid-specific PLC (73, 77, 78, lOl), Ca2+ mobilization (101,212,369), phospholipase A2 (PLA2) (74,389), PLD (388), and priming of the superoxide response (319, 321, C580 INVITED REVIEW 369). In addition, adenine nucleotides increase protein kinase C activity (12) and the accumulation of cytidine 5'-diphosphate diglyceride (342) in human neutrophils. Ca2+-mobilizing ATP receptors are expressed in neutrophils, monocytes, and macrophages. Certain macrophages, but not neutrophils and monocytes, express a second distinct type of ATP receptor. When ATP is bound, these so-called P2,-purinergic receptors induce the rapid formation of nonselective pores and/or channels that are permeated by ions and small (Cl kDa) organic molecules (49, 110, 337, 338, 346) . Brief occupation of these receptors is accompanied by a rapid depolarization and a large influx of extracellular Ca2+; these latter effects are rapidly reversed on removal of ATP. Because endogenous metabolites and ions can also pass through these pores/channels, the sustained activation of these receptors is cytotoxic (338) and impairs normal macrophage function (58, 346) . Steinberg and DiVirgilio (336) have speculated that such receptors may play a role in programmed cell death (apoptosis) or may be activated only during specific cell-to-cell contacts (e.g., antigen presentation). Expression of these cytotoxic ATP receptors occurs during in vitro differentiation of human monocytes into macrophages, and this expression is significantly enhanced with y-interferon treatment (29).
Immune System
In addition to its effects on phagocytic leukocytes and the inflammatory response, exogenous ATP can modulate the function of several immune effector cell types, including human B-lymphocytes (261, 385, 386) , certain subsets of human and murine T-lymphocytes and lymphocyte cell lines (10, 94, 123, 125, 270, 190, 355, 396) , thymocytes (108, 112, 113, 157, 178, 219) , and human natural killer (NK) cells (314). Although the in vivo function (if any) of extracellular ATP on immune responses is unknown, in vitro studies with tissue-cultured lymphocytes suggest that extracellular ATP might trigger, modulate, or attenuate diverse functional responses in lymphocytic cells, including DNA synthesis (157, 178, 355), blastogenesis (log), cell-mediated killing (123, 290, 314, 336) , and apoptosis (125, 396) .
Mechanistic studies of signal transduction have indicated that lymphocyte ATP receptors are most similar to the pore/channel-forming ATP receptors that are also expressed in macrophages. Thus treatment of ATP-sensitive lymphoid cells induces rapid depolarization (94, 112, 282), Ca2+ influx (94, 108, 112, 113, 219, 282, 385, 386) , and increased permeability to small (~400 Da) organic molecules (108, 112). In general, lymphocytes do not appear to express ATP receptors that activate G protein-dependent phospholipases and mobilization of intracellular Ca2+ stores (79, 113, 282, 336, 385) .
However, one group has described ATP-induced Ca2+ mobilization in human B-lymphocytes (261).
The ATP-induced permeabilization response observed in lymphocytes is similar to the permeabilization or lytic responses triggered by some microbial toxins [e.g., from Sendai virus (339) ] or the perforins released from cytotoxic T-lymphocytes (CTL; reviewed in Ref. 393) . Tight cell-cell junctions are known to be formed between the cytotoxic lymphocytes and target cells. ATP, released into the restricted spaces formed by this intercellular junction, might then induce pore formation in the target cells, with resulting loss of intracellular ions and nucleotides. Although this is an intriguing hypothesis, recent studies (10, 290) have indicated that ATP-induced cell death and CTL-mediated cell death can be functionally distinguished. Given such findings, Redegold et al. (290) have proposed that released ATP may act as an extracellular messenger molecule that works in concert with other secreted agents known to trigger and/or modulate lymphocyte-mediated cytolysis.
Other Blood Cells
Harden and colleagues (22, 40-43, 76, 163, 186) have extensively characterized an ATP receptor expressed in turkey erythrocytes. These studies have provided the most compelling biochemical evidence for the existence of a G protein-coupled ATP receptor that activates a particular inositol phospholipid-specific PLC isozyme. Although ATP does not appear to activate inositol phospholipid-based signaling in mammalian erythroid cells, the effects of ATP on ion transport and membrane permeability have been described in Friend erythroleukemia cells (65) and in dog erythrocytes (299) .
Endocrine-Neuroendocrine-Exocrine Secretion
Extracellular ATP can act as a secretagogue in several endocrine and neuroendocrine tissues. ATP stimulates the secretion of pancreatic hormones (insulin and glucagon) from intact pancreas (24) and from isolated pancreatic islets (23, 28, 226). Similarly, ATP induces insulin release from normal P-cells (28) and from insulin-secreting cell lines (7). These latter effects are correlated with a rapid ATP-induced increase in cytosolic [Ca2+] (7, 28, 141, 159). Human pancreatic islets and human insulinoma cells also respond to exogenous ATP with a rapid increase in cytosolic free [ Ca2+] (198) . Enhanced inositol phospholipid breakdown can be stimulated by ATP receptors in some insulin-secreting cell types (159, 271). Similar ATP receptors that activate inositol phospholipid turnover and/or Ca2+ mobilization have been identified in other secretory cells isolated from sheep pituitary gland (88, 364), human thyroid gland (289), and in the FRTL-5 thyroid cell line (254-256, 311). This latter cell line has been used to investigate the role of G proteins in mediating the various signaling events activated by these particular ATP receptors (254-256,3 11). In FRTL-5 thyroid cells, ATP-induced Ca2+ mobilization and inositol phospholipid hydrolysis are correlated with enhanced iodide fluxes (256), whereas, in porcine thyroid cells, ATP induces production of hydrogen peroxide (244). Steroidogenesis in adrenocortical fasciculata cells is likewise stimulated when P2-purinergic receptors (189) are occupied.
Exocrine secretory cell types also express ATP receptors. Acinar cells from both the parotid gland (138, 238, 333, 334) and lacrimal gland (308-309,366a) respond to extracellular ATP with a rapid increase in Ca2+ influx but not with mobilization of intracellular Ca2+ stores. These INVITED REVIEW C581 exocrine cell ATP receptors activate a pronounced depolarizing current even in the absence of extracellular Ca2+. It remains to be determined whether the ATP receptors characterized in these exocrine cells are similar to 1) the ATP-gated ion channel receptors expressed in neurons and muscle cells or 2) the pore-forming ATP receptors expressed in macrophages, lymphocytes, and mast cells.
Catecholamine release from rat pheochromocytoma cells (PC-12) can be rapidly activated by extracellular ATP (180, 234, 322) . This release is correlated with a rapid ATP-induced increase in depolarization and Ca2+ influx (180, 322) . Nakazawa and colleagues (246-248) have provided detailed electrophysiological characterization of the ATP-activated currents in PC-12 cells. Their results strongly suggest that one type of ATP receptor in PC-12 cells acts as a ligand-gated cation channel, with properties similar to those observed in some neurons and smooth muscle cells. PC-12 cells also express a Ca2+mobilizing ATP receptor that is coupled to inositol phospholipid hydrolysis (242). Chromaffin cells isolated from adrenal medulla also respond to extracellular ATP with increased cytosolic [Ca2+] (196, 307) and enhanced rates of catecholamine release (196).
Paracrine Secretory Cells: Platelets and Mast Cells
Adenine nucleotides act as potent secretagogues in two important types of paracine secretory cells: platelets and mast cells. Indeed, the ability of ADP to activate platelet aggregation, secretion, and thrombus formation has been recognized since the early 1960s (38) and represents one of most intensively studied physiological responses to extracellular nucleotides. Some of the more significant contributions to the extensive literature on platelet responses to ADP have been reviewed in Ref. 75. Because activated platelets also release ATP/ADP from granule stores, ADP can constitute a powerful paracrine signal for the rapid "feed-forward" recruitment of new platelets to the developing thrombus. Ward et al. (373) have proposed that released ATP mediates platelet-induced enhancement of the neutrophil superoxide response. It is important to note that ATP itself antagonizes the actions of ADP on platelets. Although these inhibitory effects of ATP are likely to be mediated by direct competition at the ADP receptor (75, l55), some evidence indicates that the activation of distinct ATP receptors may also be involved (335) . Platelet ADP receptors have been shown to affect many intracellular signaling pathways, including changes in Ca2+, membrane conductance, and phospholipid turnover. These responses will be discussed in detail in ADP RECEPTORS OF PLATELETS.
Mast cells express two types of receptors for extracellular ATP. At submillimolar concentrations, ATP activates a pore-forming receptor (19, 72, 146, 147) identical to that observed in macrophages. At micromolar concentrations, ATP activates a Ca2+-mobilizing receptor similar to that expressed in many other cell types (260). Mast cells can also release ATP/ADP from granule stores when Ca2+ -mobilizing immunoglobulin E receptors or ATP receptors are activated (260). Thus, for mast cells as for platelets, adenine nucleotides may constitute a very important paracrine agent for intercellular signal transduction.
Germ Cells and Reproductive System
Several cell types of the reproductive system are functionally responsive to extracellular nucleotides. ATP activates contraction in intact myometrium (259) and ligand-gated ion channel receptors in single myometrial smooth muscle cells (172). The magnitude of this ATPactivated current was reported to be greater in cells isolated from pregnant vs. control rats; in vitro treatment of the isolated myometrial muscle cells with estrogens significantly reduced the current (172). These latter results suggest that expression of these ATP receptor ion channels may be transcriptionally regulated by steroid hormone receptors. Amnion cells isolated from human placenta express ATP receptors that are coupled to inositol phospholipid breakdown and Ca2+ mobilization (363) . Extracellular ATP, acting via an as yet uncharacterized mechanism, acts as a very efficacious in vitro trigger for the acrosome reaction in human sperm (126).
Hepatic Tissue
The ability of extracellular ATP to activate inositol phospholipid hydrolysis and/or Ca2+ mobilization in freshly isolated hepatocytes has been studied in detail by several groups (66, 81, 95, 194, 257, 330) . P2-purinergic receptors coupled to Ca2+ mobilization have also been characterized in the T51B rat liver epithelial cell line (44). The rapid increase in hepatocyte [Ca2+] correlates with an ATP-induced stimulation of glycogenolysis and glycogen phosphorylase (66, 191, 194) . Similar ATP-triggered effects on glycogenolysis are observed in perfused livers (57). Depending on the extracellular concentration, ATP can either inhibit (8) or stimulate (205) gluconeogenesis in isolated hepatocytes. These metabolic effects are also correlated with the rapid release of thromboxanes and prostaglandins from livers perfused with various extracellular nucleotides (165, 358) . Nucleotides also regulate other G protein-dependent effector enzymes in hepatic tissue, including adenyl cyclase (257), PLD (34), and phosphatidylcholine-selective PLC (182). Significantly, UTP can mimic the metabolic actions of ATP in isolated hepatocytes (194) .
Functional studies suggest that hepatocytes may express several subtypes of G protein-coupled and Ca2+mobilizing receptors for ATP (194, 257, 330) . 35S-labeled adenosine 5'-O-(thiotriphosphate) ( [35S]ATPaS) has been used as a radioligand probe for characterizing putative ATP receptor sites on plasma membranes isolated from hepatic tissue (191) (192) (193) .
Renal and Intestinal Tissues
Ca2+-mobilizing ATP receptors have been identified on several types of renal epithelial cells, including rat renal cortex cells (250), MDCK cells (133,262,350), and LLC-PK1 cells (6, 375). ATP also stimulates inositol phospholipid hydrolysis and eicosanoid release in mesangial cells isolated from the renal glomerulus (272). Intestinal epithelial cells can respond to extracellular nucleotides with alterations in ion transport (197, 296 (150, 173) . Rat osteoblastic cells appear to express two distinct types of Ca2+-mobilizing ATP receptors (291). Human osteoblast-like cells also express P2purinergic receptors (3 16).
Tumor cells. Many types of transformed cells and tumor cells express P2-purinergic receptors. Even highly dedifferentiated tumor cells, such as Ehrlich ascites cells, respond to extracellular ATP with rapid activation of inositol phospholipid hydrolysis (102)) Ca2+ mobilization (loo), and an enhanced rate of Na+-H+ exchange (383) . Patch-clamp studies have revealed that ATP can activate a Ca2+-permeable nonselective cation channel in hepatoma cells (16). ATP and other nucleotides can inhibit the growth of androgen-independent prostate carcinoma cells (116). ATP has been reported to induce growth arrest of other human tumor cells in the S phase of the cell cycle (287, 288). It is unclear whether extracellular ATP exerts growth inhibitory effects by activating particular ATP receptor-based signaling cascades. The ability of ATP to inhibit the growth of transformed fibroblasts has been correlated with enhanced production of adenosine and the subsequent alteration of intracellular nucleotide pools (377) .
The characterization and cataloguing of diverse celland tissue-specific responses to extracellular ATP have clearly been important from a physiological standpoint. However, the major thrust of recent research has been to identify common elements and/or mechanisms that are involved in ATP-mediated signal transduction at both the inter-and intracellular levels. An overall perspective on ATP-mediated signal transduction should consider 1) an analysis of the sources of extracellular ATP; 2) a characterization of the metabolism of extracellular ATP; 3) the pharmacological classification of ATP receptor types and subtypes that mediate the diverse biological responses to extracellular nucleotides; and 4) the categorization, at the cellular and subcellular levels, of the various signal transduction pathways that can be regulated by extracellular nucleotides. These basic elements and relationships are illustrated in Fig. 1 .
SOURCES OF EXTRACELLULAR ATP
The diversity that characterizes ATP-induced changes in biological function has prompted both investigation and speculation as to the possible physiological sources of extracellular nucleotides. Although ATP is present in millimolar concentrations in the cytosol of all cell types, extracellular levels of the nucleotide will normally be maintained at extremely low levels by several mechanisms. First, there is generally minimal permeation of ATP or MgATP (the predominant cytosolic form) across lipid bilayers. Second, ubiquitous ecto-ATPases and ectophosphatases rapidly and efficiently hydrolyze extracellular nucleotides. Thus appreciable levels of extracellular ATP occur only transiently and in response to specific physiological and/or pathological conditions. The most obvious source of extracellular ATP is the cytosolic ATP (-3-5 mM in most cells), which can be released on sudden breakage of intact cells, as might occur during rupture of blood vessels and other types of tissue trauma. It is important to note that ATP/ADP receptors are expressed by most of the cell types that must be rapidly activated and/or recruited to minimize blood loss and invasion of pathogens at sites of tissue damage; these include platelets, neutrophils, monocytes, macrophages, vascular endothelial cells, and vascular smooth muscle cells. Two additional, and physiologically relevant, sources of extracellular nucleotides should be discussed in depth. These sources are 1) exocytotic release of ATP specifically concentrated within secretory granules or vesicles, and 2) the release of cytosolic ATP via intrinsic plasma membrane channels or pores in the absence of irreversible cytolysis.
Packaging of Nucleotides in Exocytotic Granules or Vesicles
Biochemical studies using purified secretory granules or membranes enriched in secretory vesicles have verified that ATP (and/or ADP) is copackaged with conventional neurotransmitters and local mediators within the specific exocytotic granules of many cell types. ATP is packaged with catecholamine and enkephalins in adrenal chromaffin granules (387) , with serotonin in platelet dense granules (63, 87, 239), with catecholamines in the synaptic vesicles of adrenergic nerves in the both peripheral (202) and central (382) nervous system, and with acetylcholine in the synaptic vesicles from Torpedo or Narcine electroplax organs (359, 360) . If free in solution, the concentration of ATP in chromaffin granules would be in the 100 mM range (166), and the reported molar stoichiometries of catecholamine and/or ATP within such granules vary from 3:l to 20:l. Other nucleotides, including ADP, UTP, GTP, and CTP are also present within chromaffin granules, albeit at much lower concentrations (166). Platelet dense granules also contain ATP/ADP in the 100 mM range (63). In contrast, histamine-containing granules from mast cells appear to contain a considerably lower amount of ATP/ADP (361) . The presence of ATP in many granule types have prompted speculation and investigation regarding the rapid release of ATP by specific exocytotic processes in a variety of neuronal and secretory cell types.
Exocytotic Release of ATP From Nonneuronal Cells
The most detailed studies concerning exocytotic release of ATP have been performed using nonneuronal secretory cell types that are easily isolated and maintained as single cells. These include platelets (39, 239, 374,), adrenal chromaffm cells (64, 67, 297, 298), mast cells (260), and basophilic leukocytes (260). The exocytotic release of ATP/ADP has long been recognized as a readily measured index of platelet activation (38,75,239). ATP release from intact platelets (and other cell types) can be monitored on-line by suspending cells in medium containing extracellular luciferase and luciferin and then assaying the ATP-dependent change in luciferin luminescence (64, 298). Meyers et al. (239) have calculated that intact human platelets contain ~4.5 pmol of releasable ATP plus ADP per 1011 cells. Given a normal platelet count of 3 x lo8 cells/ml blood, a concerted degranulation of platelets could transiently raise the serum concentra-tion of ATP/ADP to the 50 PM range. Most agonists known to activate platelets will induce exocytotic release of ATP/ADP; these include thrombin, epinephrine, collagen, and ADP itself (reviewed in Ref. 75).
As is true for most types of exocytotic secretion, the abilities of various agonists to elicit ATP secretion can be correlated with their abilities to trigger, via different mechanisms, rapid increases in cytosolic [Ca2+]. Intact single chromaffin cells (isolated from bovine adrenal medulla) have also been used to characterize the role of Ca2+ in regulating exocytotic release of ATP in response to direct membrane depolarization or stimulation of nicotinic acetylcholine receptors (64, 67, 297, 298) . Under all conditions, ATP secretion was blocked by removal of extracellular calcium or blockade of voltage-dependent Ca2+ channels
Mast cells express two types of receptors for extracellular ATP, and occupation of both receptor types can rapidly elicit increased cytosolic [Ca2+]. Recent studies by Osipchuk and Cahalan (260) have unequivocally demonstrated that ATP can be released from individual rat mast cells in quantities sufficient to trigger the occupation and activation of ATP receptors on adjacent mast cells. Similar patterns of ATP release and cell-to-cell communication were observed in a rat basophilic leukemia (RBL) cell line (260). The release of ATP from single RBL cells could be elicited by mechanical stimulation, by direct introduction of guanosine 5'00-(3=thiotriphosphate) (GTPyS) into patch-clamped cells, or by antigen stimulation of previously sensitized cells. ATP also stimulates mast cells to release histamine from the wellcharacterized dense granules (19,72). Histamine granules and ATP are coreleased when individual mast cells are dialyzed (e.g., during whole cell patch clamp) with solutions containing GTPyS (260). However, given the relatively low ATP content of mast cell histamine granules (361) , it remains to be determined whether ATP is released from a separate pool or subpool of exocytotic granules. The ability of mast cells and basophils to both release ATP and to respond to this nucleotide suggests that ATP can be used as a specific extracellular messenger to propagate cell-to-cell signals in the absence of direct gap junction-based communication.
When activated by appropriate antigens on target cells, cytolytic T-lymphocytes (CTL or killer T-cells) can release exocytotic granules that contain pore-forming proteins or performs (reviewed in Ref. 393 ). Because these proteins can induce formation of nonselective pores in target cells, they are likely to play an important role in the killing of target cells by CTL. Fillipini et al. (122, 123) have reported that CTL will also release intracellular ATP stores when incubated with antibodies against the T-cell receptor or with concanavalin A. Certain cells (e.g., macrophages, some T-lymphocytes, tumor cells), which are targeted by CTL, also express pore-forming receptors for extracellular ATP. These various phenomena have prompted speculation that ATP released from CTL might play a role in cell-mediated cytolysis (336, 396) . Although performs are known to be packaged in discrete exocytotic granules (393) , it remains to be determined C584 INVITED REVIEW whether the ATP released from CTL is derived from these exocytotic granules, from other granules and/or vesicles, or from the cytosolic ATP pool.
Exocytotic Release of ATP From Neuronal Cell Types
Some of the earliest speculation regarding the role of ATP as an extracellular signaling agent was based on studies of neurotransmission that was resistant to blockade by choline@ or adrenergic antagonists (reviewed in Refs. 50, 56). There is a substantial pharmacological literature that supports the hypothesis that ATP is packaged and released as a cotransmitter with norepinephrine in certain sympathetically innervated smooth muscles, principally vas deferens and some blood vessels. The reader is referred to the reviews by von Kugelgen and Starke (367) and Westfall et al. (379) for quite comprehensive listings of the various tissues and/or smooth muscles wherein ATP acts as a cotransmitter with norepinephrine. There is similar evidence that ATP is coreleased with acetylcholine in certain smooth muscles (such as urinary bladder) with cholinergic innervation (reviewed in Ref. 379) . As summarized in these reviews, studies of neuronal ATP release are based on two types of evidence: 1) the ability of ATP receptor antagonists (e.g., suramin) or desensitizing ATP receptor agonists to attenuate nerve stimulation-evoked responses in postsynaptic target cells and 2) the ability of ATP receptor agonists to mimic the responses evoked by nerve stimulation in postsynaptic target cells. These types of studies have provided compelling support for the hypothesis that neuronally released ATP may be the principal fast excitatory neurotransmitter at certain nerve-nerve synapses (105, 115, 326).
The indirect response-based studies of secretion of ATP from neuronal cell types have been complemented by direct measurements of ATP release from either intact neurons or synaptosomal preparations isolated from a variety of nerve tissues (54, 217, 325, 359, 379, 381) . These latter studies should also be consulted for the various methods used to assay ATP release from nerves or synaptosomal preparations. In general, these measurements involve incubation of the intact tissues with [3H]adenine to prelabel intracellular adenine nucleotide pools and then, after the release of 3H-labeled nucleotides/ nucleosides from the stimulated tissues/cells. Alternatively, the released extracellular nucleotides are derivatized with fluorescent tags that permit direct quantitative analysis by high-performance liquid chromatography (379) .
Release of Cytosolic ATP via Intrinsic Plasma Membrane Proteins
Given its molecular mass and anionic nature, there is generally little permeation of ATP (or MgATP) across the plasma membrane. However, several investigators have reported that cytosolic ATP (as opposed to ATP sequestered within intracellular granules/vesicles) can be released during activation of cells by physiological or pathological stimuli. Forrester and colleagues have demonstrated that cytosolic ATP can be released from intact perfused hearts (71), from isolated cardiac myocytes (127, 128), and from human erythrocytes (127), which have been metabolically compromised by hypoxia. This hypoxia-induced release is substantially attenuated by inhibitors of either anion transporters (e.g., stilbene derivatives) or nucleoside transporters (e.g., nitrothiobenzylinosine and dipyridamole).
Cytoplasmic ATP can also be released when cultured vascular endothelial cells and smooth muscle are treated with trypsin (267) or with agonists (e.g., thrombin, norepinephrine) for Ca2+ -mobilizing receptors (267, 379). Westfall and colleagues (317, 379) have presented strong data that indicate that a secondary release of cytosolic ATP from endothelial cells and smooth muscle cells may constitute a very significant percentage (90%) of the t&al ATP released on neural stimulation of certain intact blood vessels.
It is important to stress that this release of cytoplasmic ATP from various intact cells is not due to cell lysis or irreversible damage of the plasma membrane. As noted previously, the hypoxia-induced release of ATP from cardiac cells and erythrocytes can be inhibited by certain inhibitors of anion or nucleoside transporters. This suggests that noncytolytic release of cytoplasmic ATP may be mediated by specific transporter proteins. Abraham et al. (1) have described very interesting observations that suggest that the multidrug resistance (m&I) gene product (or P glyocoprotein) can function as a channel for ATP. Overexpression of P glycoprotein in transfected Chinese hamster ovary cells was accompanied by a threefold increase in the steady-state release of ATP to the extracellular medium. The rate of ATP release in other cell lines known to express m&l showed a clear correlation with the relative amount of P glycoprotein present in the plasma membrane. Significantly, patch-clamp electrophysiological measurements indicated that ATP may directly permeate the P glycoprotein channel as a charge carrier. These findings raise the possibility that other proteins that belong to the "ABC" transporter superfamily may also act as conduits for ATP release in response to diverse physiological or pathological stimuli. Overexpression of the cystic fibrosis transmembrane regulator protein has been correlated with enhanced flux of ATP from transfected cells (283).
Summary
These various sources of released ATP (exocytotic release from secretory cells, release from lysed cells, nonlytic release of cytoplasmic stores) suggest that significant amounts of ATP may locally accumulate within a variety of physiologically relevant extracellular spaces. These include 1) vascular sites of thrombus formation, 2) vascular and extravascular sites of tissue trauma and infection and/or inflammation, 3) the confined extracellular spaces that constitute nerve-nerve or nerve-muscle synapses, 4) the confined intercellular space that characterizes the direct formation of specific cell-to-cell contacts during antigen processing or cell-mediated killing, and 5) the extracellular spaces in the immediate vicinity of activated mast cells. Given the widespread expression of nucleotide receptors on many of the cell types that release ATP, it is increasingly apparent that both the INVITED REVIEW C585 release of ATP and the response to ATP in multicellular tissues involve positive feedback and feedforward interactions among diverse cells. Defining these complex pathways of ATP-mediated intercellular signaling should constitute an active area for future investigation.
METABOLISM OF EXTRACELLULAR NUCLEOTIDES
Extracellular ATP is rapidly catabolized by a variety of extracellular ATPases and nucleotidases. These "ecto-ATPase" and "ectonucleotidase" activities are variably expressed on the cell surfaces of different tissues and cells (reviewed in Refs. 264 and 397). The half-life of ATP in whole blood ex vivo is -10 min (357) . In contrast, the half-life of ATP in blood or serum perfused through the lung vasculature is ~0.2 s (304). Given the profound effects of ATP/ADP on the function of blood vessels, it is not surprising that vascular cell types express very active ectoenzymes that catalyze the rapid catabolism of ATP and ADP (reviewed in Ref. 331). Indeed, endothelial cells in the vasculature are likely to constitute the major in vivo effector system for rapidly reducing ATP levels in the blood (304). Using a recirculating perifusion system, Gordon et al. (153) have performed elegant and extensive kinetic studies of extracellular nucleotide metabolism by vascular endothelial cells and have generated estimates of the K, and maximum velocity values for the ecto-ATPase, ecto-ADPase, and 5'nucleotidase reactions. These data also suggested that ATP and ADP can feedforward inhibit the 5'nucleotidase. This will attenuate the production of adenosine and thus limit activation of adenosine receptors during the initial phases of local ATP/ADP release. The stereoselectivities of the various enzymes that act as ectonucleotidases have also been characterized in considerable detail in endothelial cells (84, 266) and vascular smooth cells (265).
Biochemical Characterization of Ecto-ATPases and Ectonucleotidases
Highly active Ca2+-Mg2+-ATPase activities in plasma membranes from pancreas (162), liver (222), and Ehrlich tumor cells (300) have been identified as ecto-ATPase activities. The major Mg2+-ATPase activity associated with T-tubule membranes from skeletal muscle also appears to be an ecto-ATPase (305). Lin and Russel (222) have identified two distinct Ca2+-Mg2+-ATPases in hepatic plasma membranes. One is a 100~kDa protein that acts as an ecto-ATPase, whereas the other is the wellcharacterized 118.kDa ATPase that acts as a Ca2+ transporting pump. Several parameters differentiate these ATPase activities: I) the former exhibits a broad nucleotide selectivity, whereas the latter selectively utilizes ATP; 2) a phosphorylated intermediate is formed during the catalytic cycle of the Ca2+ pump ATPase but not the ecto-ATPase; and 3) vanadate inhibits the pump ATPase but not the ecto-ATPase. Lin and Guidotti (221) have isolated a cDNA clone that may encode this hepatic ecto-ATPase. They have demonstrated that it is preferentially expressed in canalicular (as opposed to sinusoidal) plasma membranes isolated from liver. The cDNA sequence suggests that the putative ecto-ATPase possesses at least one transmembrane-spanning domain and a largely extracellular NH2-terminal domain. It remains to be determined whether the ecto-ATPases from nonhepatic tissues are homologous to this liver ecto-ATPase. Recent studies have indicated that this canalicular ecto-ATPase may play a variety of roles. Lin et al. (220a) demonstrated that this ecto-ATPase is immunologically and structurally identical (in terms of isoelectric points, V&proteinase peptide mapping, and migration on reducing vs. nonreducing) to the CAM 105 glycoprotein celladhesion molecule. This suggests that the ecto-ATPase protein may be involved in cell-cell adhesion. In addition to this potential role in cell adhesion, the liver ecto-ATPase has been shown to act as a canalicular bile transport protein.
The biochemistry and cell biology of the 5'.ectonucleotidase has been extensively characterized; the recent review by Zimmermann (397) provides a comprehensive listing of this literature. The ubiquitously expressed 5'. ectonucleotidase is a disulfide-linked dimer comprised of two glycophosphatidylinositol (GPI)-anchored protein subunits (with apparent molecular masses of 60-80 kDa). This 5'-ectonucleotidase catalyzes the hydrolysis of AMP to adenosine or (IMP to inosine) and is inhibited by ATP and ADP.
Functions of Ecto-ATPases and Ectonucleotidwes
The various ecto-ATPases and ectonucleotidases presumably serve at least two major roles (Fig. 1 ). The first is termination of ATP/ADP-induced signal transduction. The rapid breakdown of ATP (and ADP) will act to reduce the extracellular concentrations of these nucleotides within the vicinity of Pa-purinergic receptors that mediate the various biological reponses to ATP and ADP. Differential expression (quantitative and/or qualitative) of ectonucleotidases on the surface of target cells, which also express ATP receptors, can significantly affect the local concentration of released nucleotides and thereby attenuate the magnitude or duration of ATP-induced signaling. For example, Slakey et al. (331) have hypothesized that the high ATPase and ADPase activities of vascular endothelial cells may be important to limit platelet activation and thrombus formation to the site of local tissue damage. Given the sensitivities of endothelial cells, platelets, neutrophils, and monocytes to submicromolar and/or micromolar concentrations of ATP/ADP, even modest increases in serum nucleotide levels could induce inappropriate thrombus formation, inappropriate accumulation of activated phagocytes, and secondary tissue damage, due to the release of reactive oxygen species and cytolytic enzymes from the activated phagocytes. The high ecto-ATPase activity associated with CTL may protect these cells from the cytolytic effects produced by the pore-forming ATP receptors expressed in these and other lymphocytes (122).
A second role for these e&enzymes is to catalyze the generation of adenosine (and adenosine metabolites) that, after reuptake into the cells, serve to replete intracellular purine nucleoside and nucleotide pools (reviewed in Ref. 48). The adenosine that is generated extracellularly, as a product of ecto-ATPase and/or nucleotidase reactions, can also serve as an agonist for the nucleosideselective Al-or A2-adenosine receptors (reviewed in Refs.
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INVITED REVIEW 48, 223). For this reason, caution should be exercised when assuming that a particular cellular response to extracellular ATP involves the activation of P,-type purinergic receptors per se. In addition to adenosine derived from the extracellular catabolism of released ATP, cytosolic adenosine (generated via hydrolysis of intracellular ATP/ADP) can be specifically released from intact cells under a variety of physiological or pathological situations (48). Particular attention has been focused on the release of intracellular adenosine that rapidly accumulates in cells during conditions of decreased energy supply (e.g., hypoxia, ischemia) or increased energy demand (e.g., exercise). As is the case for ATP, extracellular adenosine has a short (subminute) half-life within in vivo extracellular spaces. This is due to existence of I) efficient nucleoside transport mechanisms for reuptake into the cells and 2) utilization of adenosine by enzymes such as adenosine deaminase. Differential expression of ecto-ATPases and ectonucleotidases in particular cell types may also serve to regulate the local production of adenosine for signaling roles in particular tissue contexts. For example, human B-lymphocytes, but not T-lymphocytes, express high levels of ecto-ATPase and ecto-5'.AMPase (13). In contrast, several functions of T-lymphocytes, but not B-lymphocytes, can be modulated when occupied by adenosine receptors (13,37,97). Barankiewicz et al. (13) have speculated that B-lymphocyte ecto-ATPase generates adenosine, which may serve to modulate the immune function of T-lymphocytes. Slakey et al. (331) have similarly noted that the capacity of vascular smooth muscle cells to generate adenosine from extracellular ATP is considerably greater than the capacity of endothelial cells. This adenosine may be used for feedback modulation of adenosine receptors on the presynaptic neurons that release ATP (Ref. 328 and reviews in Refs. 48,52, and 56).
Some cells express both adenosine receptors and ATP receptors. When initially exposed to extracellular ATP, the ATP receptors will be activated. However, adenosine receptors will subsequently be activated as the ATP is progressively metabolized to adenosine. Depending on the cell type, adenosine receptors can activate signaling cascades that either attenuate or potentiate the biological responses triggered by ATP receptors. For example, activation of AZ-adenosine receptors increases adenosine 3',5'-cyclic monophosphate (CAMP) accumulation in neutrophils, and this is associated with inhibition of superoxide generation and exocytotic granule release (83). These inhibitory actions of adenosine oppose the stimulatory effects of ATP on these parameters of neutrophil function. Conversely, adenosine, acting at A1 -adenosine receptors, acts synergistically with ATP to activate both inositol phospholipid hydrolysis and Ca2+ mobilization in DDTJW-2 smooth muscle cells (140).
Extracellular ATP as a Substrate for Ectokinase Activities
In addition to acting as a substrate for diverse nucleotidases, extracellular ATP can be utilized by kinase activities that appear to be localized on the surface membrane of some cells. Putative ectokinase activities have been characterized in NG108-115 neuroblastoma x glioma hybrid cells (106-108), HeLa cells (210,21 l), cultured myoblasts (68, 225) , and NK cells (243). Pirotton et al. (278) have recently characterized a staurosporine-sensitive ectokinase activity on aortic endothelial cells. These observations are generally based on measuring the phosphorylation of surface proteins (or exogenous peptide substrates) in intact cells under conditions that minimize cell disruption and the release of intracellular kinases (these methods are reviewed in Ref. 199) . The phosphorylation of cell surface proteins has been correlated with altered ion fluxes in NGl08-115 cells (107), with cell fusion in cultured myoblasts (225), and with the modulation of NK cell function (243). Additional studies are required to unequivocally establish whether these ectokinase activities act as true effecters of ATP-mediated signal transduction. Research during the past several years has greatly increased our appreciation of the number and diversity of cell surface receptors that are involved in transmembrane signaling. In particular, the application of molecular biological methods has facilitated the identification of the cDNA or genomic DNA that encode many of these receptors. These structural data, in conjunction with the results of functional (both physiological and biochemical) studies, have indicated that signal-transducing receptors can be broadly categorized into several major classes (reviewed in Ref. 170) as follows: I) receptors that act as multisubunit ligand-gated ion channels, 2) G proteincoupled receptors with seven-transmembrane spanning domains, 3) receptors with intrinsic catalytic activity (typified by the receptor tyrosine kinases), and 4) multisubunit receptors that lack intrinsic catalytic function (typified by the T-cell receptor and many cytokine receptors). In general, these latter receptors and the receptors with intrinsic catalytic activities recognize ligands that are large polypeptide growth factors, hormones, or cytokines. In contrast, receptors that act as ligand-gated ion channels bind small organic molecules that function as neurotransmitters;
these ligands include acetylcholine, y-aminobutyric acid (GABA), glutamate, and glycine. The G protein-coupled receptors (reviewed in Ref. 96) constitute a large superfamily of receptors for many structurally diverse ligands, including small organic molecules (e.g., catecholamines and prostaglandins), small (3-10 amino acids) peptides (e.g., vasopressin), and larger (20-40 amino acids) polypeptide hormones (e.g., glucagon). Given that ATP is a relatively small organic ligand, the various ATP receptors are most likely to belong to the superfamilies of the G protein-coupled receptors and/or the ligand-gated ion channel receptors. Although this hypothesis is consistent with the results of most functional studies, a definitive evaluation awaits the isolation and/or cloning of the various functionally defined ATP receptor types.
From the preceding review of the diverse biological INVITED REVIEW C587 actions of extracellular ATP, it is evident that ATPinduced responses in most tissues and cells can be ascribed to, or correlated with, alterations in cellular Ca2+ homeostasis. Indeed, the utilization of fluorescent Ca2+ indicator dyes and appropriate spectrofluorometric methods has been particularly useful in defining ATP-induced signal transduction pathways in numerous cell types. Many studies during the past several years have documented that extracellular ATP rapidly (within seconds) increases cytosolic [Ca2+] in the vast majority of cell/ tissues that exhibit ATP-induced changes in function. In turn, the ATP-induced increases in cytosolic [Ca2+] can activate a host of secondary signal-transduction processes that have been associated with ATP-induced responses in particular tissues and cells. These include I) the stimulation of diverse Ca2+-dependent regulatory en-ZyIlles, including calmodulin-dependent kinases, 2) stimulation of PLA2 with consequent production of various eicosanoids, 3) the activation of Ca2+-dependent exocytotic events, and 4) activation or inhibition of various plasma membrane ion channels (e.g., Ca2+-activated K+ channels), with consequent changes in membrane potential and excitability.
Although Ca2+ appears to play a key role in most biological reponses to ATP, a comparison of the ATP/ADPinduced increases in cytosolic [Ca2+] observed in diverse cell types indicates that these increases are mediated by several distinct mechanisms of action. The different mechanisms that mediate ATP/ADP-induced increases in cytosolic [Ca2+] are summarized in Fig. 2 , and a comparison of these mechanisms provides a useful context for discussing the major types of P2-purinergic receptors. Such comparisons, together with other functional characterizations, strongly suggest that there are at least four major types/classes of P2-purinergic receptors for ATP. The ADP receptor expressed in platelets constitutes a fifth class of nucleotide receptor. As will be discussed below, two of the ATP-selective nucleotide receptors and the ADP-selective receptor appear to act as ligand-gated channels, whereas two of ATP-selective receptors function as G protein-coupled receptors. PHARMACOLOGICAL 
CLASSIFICATION OF P,-PURINERGIC RECEPTORS
Functional studies have provided the strongest support for the existence of distinct ATP receptor types and subtypes. However, pharmacological classification of receptor types or subtypes has traditionally involved establishment of the "rank-order of potency" that characterizes the ability of naturally occurring or synthetic ligands (either agonists or antagonists) to interact with particular receptors. These agents can be used either to characterize the biological response presumably initiated by a given receptor subtype, or, in combination with selective highaffinity radiolabeled probes, to directly characterize the ligand-binding properties of the receptor. Similar approaches have been used for the classification of P2-purinergic receptors. Although highly selective antagonists for these receptors have yet to be identified or synthesized, various other nucleotides (both natural and synthetic) have been shown to mimic, with different potencies, the ability of ATP to elicit diverse biological responses. Nucleotides can be structurally modified in three major domains: the base moiety, the ribose (or deoxyribose) group, and the polyphosphate chain. Particularly useful ATP analogues are those containing substitutions at the 2'-hydroxyl of the ribose or substitutions of methylene bridges for the normal oxygen bridges of the polyphosphate chain. As summarized in Table 1 and in previous reviews (56, 99, 154, 190, 253, 258, 320) , at least five distinct types of nucleotide receptors can be grouped on the basis of their selectivities for various nucleotides. These include four ATP receptor types, termed P2,-P2y', P 2u-(or 5'-nucleotide), and P2,-purinergic receptors. The ADP-selective receptor expressed in platelets has been denoted as the Pat (for "thrombocyte") purinergic receptor.
In general, each of these pharmacologically defined re-EXTRACELLULAR ADP ceptor types can be matched with one of the functionally defined receptor types (Table 1) that will be discussed in detail. Thus Pz,-receptors function as G protein-coupled Ca2+-mobilizing ATP receptors, P&ype receptors act as ligand-gated ion channels, and PZ,-receptors are associated with ATP-induced pore formation. Many investigators have identified another G protein-coupled Ca2+-mobilizing nucleotide receptor that can be activated by ATP and other nonadenine nucleotide trisphosphates; UTP is a particularly potent and efficacious agonist for this receptor (reviewed in Refs. 99, 253, 320). This Ppu or 5'nucleotide receptor is functionally similar to, but pharmacologically distinct from, the Pz,-receptor class. Functional studies suggest that this receptor may be one of the more widely expressed of the various ATP receptors. As summarized in the recent review by Bean (l5), receptors with differing nucleotide selectivities, including the well-characterized P&ype pharmacology, can function as ligand-gated ion channels. The growing number of pharmacologically "anomalous" ATP receptors suggests that the major classes of functionally defined ATP receptors may represent a number of related, but genetically distinct, subtypes. At present, no compounds have been identified as reagents that can selectively bind to, and functionally antagonize, the various functionally defined Pz-purinergic receptor types/subtypes. In contrast, several compounds, which are known to interact with multiple ATP-binding enzymes/proteins, have proven to be useful as functional antagonists of ATP receptor-based signaling in some tissues/cells. Fedan and Lamport (119) have reviewed the list of compounds that have been employed as functional antagonists of ATP-induced signal transduction. Some of these reagents, such as 4,4'-diisothiocyanostilbene-2,2'disulfonic acid (DIDS), are known to interact with multiple types of intrinsic membrane proteins (e.g., anion transporters). Other compounds, such as reactive blue 2 and 5'.p-fluorosulfonylbenzoyladenosine (FSBA) , have been extensively used as affinity reagents for the purification or labeling of multiple enzymes that bind and/or utilize nucleotides as substrates or cofactors. Recently, the drug suramin has proven to be an efficacious and reversible antagonist of 1) the ATP receptors that act as ligand-gated ion channels in celiac neurons (115, 326, 327), media habenula neurons (105), PC-12 cells (248), and vas deferens smooth muscle (104); and 2) the Ca2+mobilizing (and presumably G protein-coupled) ATP receptors expressed in mast cells (260), rat basophilic leukocytes (260), PC-12 cells (242), and DDTiMF-2 smooth muscle cells (169). In many cell types, the functional effects elicited by exposure to extracellular ATP can be correlated with an ATP-induced mobilization of intracellular Ca2+ stores (Table 2) . Consistent with this Ca2+-mobilizing action (2l), extracellular ATP and other nucleotides have been reported to induce rapid activation of inositol phospholipid hydrolysis and accumulation of Ins( 1,4,5)P3 in many of these cells. These effects are generally elicited in response to ATP in the low8 to 10e4 M concentration range. Thus certain ATP receptor subtypes are likely to belong to the superfamily of cell surface receptors that are functionally coupled to inositol phospholipid-specific PLC (PI-PLC) effector enzymes. As is true for most agonists that activate PI-PLC (reviewed in Ref. 2l), ATPinduced accumulation of inositol polyphosphates is usually accompanied by increased influx of extracellular Ca2+. Ca2+ mobilization and Ca2+ influx also underlie the marked activation of Ca2+-dependent K+ channels that is observed when certain cells are treated with extracellular ATP (133, 240, Similar to many other Ca2+-mobilizing receptors, P2purinergic receptors appear to indirectly activate PI-PLC effector en .zymes via the mediation of guanine nucleotidebinding regulatory proteins (G proteins). In some (but not all) ATP-responsive cell types, the ability of P2-purinergic agonists to elicit inositol polyphosphate accumulation and Ca2+ mobilization is inhibited or attenuated on pretreatment of the cells with pertussis toxin (11, 47, 73,74,77,101,124,176,254-256,272, 343, 351, 369, 389) .
Several cell-free or permeabilized cell systems have been described for the characterization of ATP receptor-G protein-PI-PLC signaling cascades under defined in vitro conditions. These preparations include membrane ghosts from turkey erythrocytes (41-43), membranes from HL-60 myeloid leukocytes (77, BO), membranes from FRTL-5 thyroid cells (254), permeabilized human airway epithelial cells (47), and permeabilized endothelial cells (45). In such preparations, the ability of Ps-purinergic agonists to activate PI-PLC is greatly potentiated by the additional presence of guanine nucleotides.
As discussed previously, G protein-dependent PI-PLC can be activated by two pharmacologically distinct ATP receptors (Fig. 2, Table 1 ). In certain cells, including some endothelial cells and avian erythrocytes, ADP is equipotent to ATP. In these cells, nonadenine (both purine and pyrimidine) nucleotides are generally inactive or much less potent than ATP/ADP. This nucleotide selectivity is characteristic of the P2,-purinergic receptor subtype. Conversely, in many other cell types, including phagocytic leukocytes, fibroblasts, and airway epithelial cells, ADP is several orders of magnitude less potent than ATP in stimulating PI-PLC and Ca2+ mobilization. However, these latter cell types can be activated by other nonadenine nucleotide triphosphates, with UTP being a particularly potent agonist. Recent studies have indicated that certain endothelial cells (228,229,286), hepatocytes (95, 165, 194, 358) , and osteoblasts (291) may express both subtypes (P2Y and P2J of PI-PLC coupled Ca2+mobilizing ATP receptors (reviewed in Ref. 253).
In some cells that are responsive to both UTP and ATP, there are subtle differences between the responses to these two nucleotides. Seifert and colleagues (319) (320) (321) have proposed that UTP may act by binding to specific pyrimidinoceptors, rather than by binding to a nucleotide receptor that recognizes both ATP and UTP. Although this possibility cannot be dismissed, it should be noted that no cells have been identified that respond only to uridine nucleotides. Moreover, in several cells that mobilize Ca2+ in response to ATP and UTP, each nucleotide completely cross-desensitizes the response to the other nucleotide (47,369) but not to other Ca2+-mobilizing agonists (which argues against heterologous desensitization).
Biochemical Identification of the Signaling Elements That Mediate ATP-Induced Activation of G Protein-Dependent PI-PLC Enzymes
P2Y-purinergic receptors. Thus far, no putative G protein-coupled ATP receptor has been purified to homogeneity, nor have the genes encoding such receptors been cloned (see NOTE The ability of guanine nucleotides to modulate the highaffinity binding of receptor agonists is a hallmark of receptors coupled to heterotrimeric G proteins (96, 144). Thus the turkey erythrocyte data provide the most direct support for the hypothesis that the Ca2+-mobilizing Psy' receptor subtype is indeed coupled to a heterotrimeric G protein. Harden's group (40, 42) has also demonstrated that treatment of turkey erythrocyte membranes with 32P-labeled benzoylbenzoic-ATP (BzATP; a nucleotide photoaffinity probe) yields a light-catalyzed, preferential incorporation of 32P into a 53-kDa membrane protein. have likewise reported that Ca2+-mobilizing Pz,-receptors can also be expressed in oocytes injected with mRNA from mouse macrophages, Micromolar concentrations of ATP or UTP are sufficient to activate Ca2+ mobilization and Ins(1,4,5)P3 accumulation in most cells. Divalent cation-complexed nucleotide is the predominant form of ATP in physiological media that contain -1 mM each of Ca and Mg. However, studies with several cell types have suggested that the metal ion-free nucleotide (ATP4-), rather than the divalent cation-complexed form, may constitute the actual ligand that activates the P2u-or 5'nucleotide receptors (47,88,124,228,351).
Thus reducing or eliminating extracellular Mg and Ca significantly increases the biological potency of ATP and UTP. This suggests that the receptor has appreciable affinity for ATP4-or UTP4-in the nanomolar range. It should be noted that ATP4appears to be the preferred agonist for other ATP receptor types, including the Pax ligand-gated channel receptor (118) and the Paz pore-forming receptor (72, 112, 147, 282, 302, 337, 348) .
G Proteins and PI-PLC Isoforms That Mediate the Activation of Inositol Phospholipid Hydrolysis by ATP Receptors
As noted previously, ATP receptors can activate PI-PLC enzymes by both pertussis toxin-sensitive and -insensitive mechanisms (Table 2) . Pertussis toxin-insensitive activation characterizes cells that primarily express P2 -type & receptors. P2&ype receptors appear to be capa le of activating either pertussis toxin-sensitive or -insensitive pathways (or both) in a cell type-specific manner. As reviewed by Sternweis and Smrcka (340) , recent studies have greatly advanced our understanding of the particular G proteins and PI-PLC isoforms (292) that mediate the pertussis toxin-insensitive activation of ino-sit01 phospholipid hydrolysis by various Ca2+-mobilizing receptors. In vitro studies (Ref. 352 and review in Ref. 340) have demonstrated that the PI-PLC@l isoform can be activated by the a-subunits belonging to the recently identified Gq/Gll class of heterotrimeric G proteins (341); these G protein a-subunits are not ADP-ribosylated by pertussis toxin. Significantly, Waldo et al. (368) have purified a turkey erythrocyte-derived G protein a-subunit that is immunologically related to the G, a-subunits and is capable of activating a purified turkey erythrocyte PI-PLC. This G protein mediates the pronounced activation of the turkey erythrocyte PI-PLC (which is related to mammalian PI-PLCP) by Pg,-purinergic receptors. Thus it is likely that the PzY receptors expressed in mammalian cells also trigger a similar Gq/ PI-PLCpl signaling cascade.
Despite significant efforts, the activation of various purified PI-PLC isoforms by a-subunits of the known pertussis toxin-sensitive G proteins has not been accom-plished. However, several groups have recently indicated that the @y-subunits from such G proteins can activate the cytosolic PI-PLC/32 isoform isolated from HL-60 cells (59,188) and a cytosolic PI-PLC derived from liver (30). Moreover, when COS cells are cotransfected with cDNA encoding PI-PLCB2, M2-muscarinic receptors, and various G protein p-and y-subunits, there is a large increase in the pertussis toxin-sensitive accumulation of inositol phosphates stimulated by carbachol(l88). It is important to note that 1) PI-PLC@B is the major PI-PLC isoform expressed in HL-60 cells (59) and 2) that Pa,-receptors stimulate a robust pertussis toxin-sensitive activation of inositol phospholipid breakdown in these particular cells (73, 77, 101). It will be interesting to determine whether a /3r/PI=PLCp2 signaling cascade mediates the ability of ATP/UTP receptor to stimulate pertussis toxin-sensitive Ins(1,4,5)P3 accumulation in diverse cell types.
Activation of Other G Protein-Regulated Responses by ATP Receptors
The ATP receptors that stimulate G protein-dependent PI-PLC enzymes have been shown to activate or inhibit other signal transduction pathways that are (or may be) regulated by heterotrimeric G proteins. For example, ATP inhibits, via a guanine nucleotide-dependent mechanism, the so-called voltage-dependent M current (a K+ channel) characteristic of certain neurons (46). ATP has been reported to inhibit CAMP accumulation and/or adenyl cyclase activity in LLC-PKi renal epithelial cells (6), hepatocytes (257), C6 glioma cells (275), and FRTL-5 thyroid cells (311). These latter effects are sensitive to pertussis toxin and appear to be independent of ATPinduced PI-PLC activity and Ca2+ mobilization. Vassort and colleagues (365) have proposed that ATP receptors in rat cardiac myocytes may activate a G,-type G protein that is directly coupled to the stimulation of L-type Ca2+ channels.
The PI-PLC-coupled ATP receptors also activate a variety of other phospholipase-based signal transduction reactions. As is true for most agonists that increase intracellular [ Ca2+], extracellular nucleotides stimulate arachidonic acid release and eicosanoid production in a wide variety of cell types (61, 62, 74, 129, 158, 165, 175, 229, 255, 263, 269, 272, 273, 347, 358, 389) .
ATP-induced arachidonic release may reflect a secondary activation of PLA2, which results from the primary activation of a G protein-dependent PI-PLC, with attendant Ca2+ mobilization and stimulation of protein kinase C. However, there is some evidence that ATP receptors may directly regulate PLA2 activity by G protein-mediated mechanisms that are independent of PI-PLC activation (74, 158, 389) . ATP receptors have been reported to activate G protein-dependent phospholipases (both C and D), which selectively hydrolyze phosphatidylcholine in hepatocytes (182), endothelial cells (236, 280, 286), arterial smooth muscle (249), and HL-60 granulocytes (388). Increased activity of these latter enzymes, in concert with the stimulation of PI-PLC, may underlie the large ATPinduced accumulation of diglyceride and phosphatidic acid observed in many cells. There is much current interest in characterizing the roles of phosphatidylcholine- 
Tissue Expression and General Characteristics
Patch-clamp electrophysiological recordings of both whole cell currents and single-channel currents have facilitated the identification of ATP receptors that act as ligand-gated ion channels in a growing variety of excitable cell types that include both neurons and muscle cells (Table 3 ). In all of these cells, nanomolar to micromolar concentrations of extracellular ATP directly activate depolarizing currents, without the apparent involvement of G proteins or soluble second messengers. These observations indicate that ATP can be added to the relatively small group of physiological compounds (acetylcholine, glutamate, GABA, glycine, and serotonin) that act as extracellular agonists for ligand-gated ion channels. It is likely that these ATP-gated ion channels are the PZpurinergic receptors that mediate fast excitatory neuro-transmission or coneurotransmission at the several types of nerve-nerve (105, 115, 137, 326, 327) or nerve-muscle synapses (31, 52, 56, 168, 367, 379) .
Although there are some differences in the ATP-activated conductance pathways observed in these various cell types, several common features may be noted, and these have been summarized in the comprehensive minireview by Bean (15). These include 1) permeation by most small cations with relatively little selectivity for different monovalent cations; 2) substantial activity even at hyperpolarized membrane potentials; 3) activation within milliseconds and, in general, rapid inactivation; and 4) an apparent lack of involvement of either G proteins or diffusible second messengers (Ca2+, CAMP) in generating the increased ionic conductances. Thus ATPgated ion channels are most similar to the excitatory neurotransmitter-gated channels, such as the nicotinic acetylcholine receptor and the N-methyl-D-aspartate-activated glutamate receptors. Under physiological conditions, occupation of these ATP receptors will induce a rapid depolarization of the target cells, with Na+ acting as a predominant charge carrier (17, 69, 115, 137, 177, 179, 246, 313) . The ATP-gated channels in artery smooth muscle cells (17), PC-12 cells (226), and sensory neurons (209) are also permeable to larger cations such as glucosamine and tris(hydroxymethyl)aminomethane.
Although the permeation of cations through all types of ATP-gated ion channels has been well characterized, Thomas and Hume (353) have reported that small anions 1 1 l 1 P. 1 11 . receptors that act as ligand-gated ion channels. In all cases, responses to ATP or other nucleotides have been characterized by direct electrophysiological measurements. In certain cells, ATP-gated channels have been shown to directly mediate a considerable influx of extracellular Ca 2+ (direct Ca2+ influx). In other cell types, ATP-induced depolarization has been associated with secondary activation of voltage-gated Ca2+ channels (indirect Ca2+ influx). Pharmacological characterization has indicated that ATP-gated ion channels in various tissues can belong to P2,-subtype (+), to distinctive non-P,,-subtype (-), or to receptor that exhibits some, but not all, features of a P&ype pharmacology (+/-). ND, not determined. can also permeate the ATP-activated channels expressed in developing skeletal muscle cells. ATP-activated singlechannel currents have been measured in some neurons (120, 207), smooth muscle cells (17), and PC-12 cells (247); these single-channel conductances lie in the lo-60 pS range. The kinetics of ATP-gated channel opening, closing, and inactivation have yet to be characterized in detail at the single-channel level.
ATP-Gated Ion Channels and Ca2+-Based Signal Transduction
In most cell types, activation of these ATP-gated ion channels is associated with a rapid increase in cytosolic [Ca2+] (5, 17, 27, 31, 69, 90, 91, 117, 183, 187, 284, 315, 322, 323) . In certain of these cells, such as rabbit ear artery smooth muscle cells (17), bladder smooth muscle cells (183,315), cochlear hair cells (323) , and PC-12 cells (117, 246, 322) , the direct flux of extracellular Ca2+ through the ATP-gated channel constitutes a significant source of the ATP-induced increase in cytosolic [Ca2+]. These observations correlate with electrophysiological data that indicate that Ca2+ can permeate most of the ATP-gated ion channel receptors that have been characterized in various cell types. It should be noted that the relative Ca2+/Na+ permeability of these gated channels has ranged from a high value of 3:l in ear artery smooth muscle (17) to 0.3: 1 in sensory neurons (15) .
The opening of ATP-gated cation channels will also result in depolarization of the plasma membrane (due to Na+ acting as the predominant charge carrier) and the secondary activation of voltage-dependent Ca2+ channels. The ability of ATP to increase Ca2+ influx and cytosolic [Ca2+] in some cells can be reduced by organic and inorganic inhibitors of voltage-gated Ca2+ channels. These effects range from partial inhibition of ATP-induced Ca2+ influx [e.g., in bladder smooth muscle (31, 183,187) to nearly complete inhibition in cardiomyocytes (5,27,91)]. It is likely that the stimulation of ATP-gated channels in most excitable cells may increase cytosolic [Ca2+] through a combination of direct receptor-gated Ca2+ influx and indirect activation of voltage-gated Ca2+ influx. In cardiomyocytes, ATP-induced depolarization and Ca2+ influx also leads to the mobilization of the intracellular ryanodine-sensitive Ca2+ stores (9 1).
ATP-induced Ca2+ influx, in the absence of inositol phosphate accumulation and mobilization of intracellular Ca2+ stores, has also been described in several endocrine/ exocrine secretory cells, including parotid gland acinar cells (238,333,334), lacrimal gland acinar cells (308,309), and the HIT pancreatic P-cell line (141) . Some lines of evidence suggest that the receptors that mediate these responses in acinar cells may be more closely related to the pore-forming ATP receptors described below than to the ATP-gated ion channels that are characteristic of neurons and muscle cells.
Pharmacological and Biochemical Characterization of ATP-Gated Ion Channel Receptors
In general, all ATP-gated ion channels characterized thus far exhibit a high selectivity for adenine nucleotides.
ATP is invariably the most potent of the naturally occurring nucleotides, and adenosine has no effect (summarized in Ref. 15 ). The ATP-gated ion channels expressed in some cells exhibit a nucleotide selectivity characteristic of the pharmacologically defined P2&pe purinergic receptors; examples include vas deferens smooth muscle (118, 119, 168) , bladder smooth muscle (31, 315), ear artery smooth muscle (18), other vascular muscle cells (reviewed in Ref. 367) , and some neurons (105, 120). A common feature noted in all of these cells is the ability of &methylene ATP (a selective agonist for P2&pe receptors) to induce rapid activation and inactivation of these receptors and thereby desensitize the cells to subsequent stimulation by ATP per se. However, other ATPgated ion channels expressed in PC-12 cells (246), rat ventricular myocytes (go), and bullfrog atrial cells (135) exhibit a different nucleotide selectivity in which cu,/3methylene ATP is a poor agonist. Thus, as is true for G protein-coupled ATP receptors, ATP-gated ion channel receptors may constitute a family of functionally related, but pharmacologically distinct, receptor subtypes. There is ample precedent for this, given the existence of multiple nicotinic receptor subtypes.
Several approaches have been used to identify and to biochemically characterize the nucleotide-binding sites that constitute these ATP-gated ion channel receptors. Fedan and colleagues (118, 168) demonstrated that ary-1azidoaminoproprionyLATP (ANAPP3) can both activate and desensitize P2&pe receptor ion channels in vas deferens smooth muscle. In the presence of appropriate irradiation, these ANAPP%occupied receptors become irreversibly desensitized. Using [ 3H] ANAPP3, these investigators indicated that photochemical incorporation of radioactivity was limited to two membrane proteins with apparent molecular masses (on SDS-polyacrylamide gels) of 57 and 66 kDa (119); ATP itself antagonized the photolabeling of these protein bands. Two groups have used cu,/3-[3H]methylene ATP to reversibly label putative P2,-receptor binding sites in membranes isolated from either bladder smooth muscle or vas deferens (31, 32, 303). The high-affinity (& in the 2-10 nM range) binding of cu,@-[3H]methylene ATP to these membranes was displaced by other nucleotides with a potency order characteristic of P2,-type receptors. In recent studies, Bo et al. (33) have solubilized these &-[3H]methylene ATP binding sites and have covalently labeled the high-affinity sites using ultraviolet irradiation; radioactivity was predominantly incorporated into a membrane protein with an apparent 62kDa molecular mass. Finally, Giannattasio et al. (142) have indicated that 8-azido-ATP can be used to photochemically inactivate the ATP receptor ion channels expressed in rat ventricular myocytes (142); experiments with 8-azido-[at-32P] ATP revealed the selective radiolabeling of a 48-kDa membrane protein.
It remains to be determined whether standard biochemical approaches can be used to purify and partially sequence the nucleotide-binding proteins identified in these various studies. At present, no reports have been published regarding the purification, reconstitution, or molecular cloning of any receptors that act as ATP-gated c594 INVITED REVIEW ion channels. Given the structures of previously characterized ligand-gated channel receptors (170), it is possible that these particular ATP receptor types/subtypes may be composed of multiple protein subunits, each of which is a separate gene product. This may complicate, but not nullify, the application of expression-cloning strategies for the isolation of the cDNA(s) that encode the receptor subunits (332) .
ATP RECEPTORS THAT INDUCE FORMATION OF NONSELECTIVE PORES Tissue Expression and Basic Characteristics
In 1977, Rozengurt, Heppel, and Friedberg (302) reported that extracellular ATP could alter the membrane permeability properties of certain transformed (but not untransformed) murine fibroblasts. When treated with submillimolar ATP, the responsive fibroblasts rapidly released their endogenous nucleotides and other normally impermeable metabolites to the extracellular medium. During the intervening 15 years, other investigators established that this ATP-induced loss of endogenous metabolites reflects the formation (or activation) of nonselective pores that mediate a generalized bidirectional increase in plasma membrane permeability to molecules as large as 900 Da. Thus responsive cells not only release endogenous molecules and ions but also become hyperpermeable to extracellular molecules such as Ca2+, other ions, and exogenous organic molecules. In contrast to the broad varieties of cells and tissues that express G proteincoupled ATP receptors or ATP-gated ion channel receptors, the expression of these pore-forming ATP receptors appears to be considerably more limited. This type of ATP-induced response has been well-characterized in macrophages (25, 49, 111, 156, 252, 337, 338, 346) , mast ceils (19, 72, 348, 349) , and certain types of transformed fibroblasts (93, 114, 132, 148, 149, 164, 281, 302, 339, 376) . In all of these cells, prolonged opening of these ATP-induced pores or channels will lead not only to equilibration of transmembrane ionic gradients (and hence to the increase in the intracellular Ca2+) but also to loss of the critical intracellular metabolites (e.g., nucleotides) and eventual cell death. Steinberg and Silverstein (338) have utilized this cytotoxic response to generate mutant sublines of the 5774 mouse macrophage line, which are resistant to these permeabilizing and cytotoxic effects of extracellular ATP. Studies using these mutant cell lines have verified that these pore-forming receptors are distinct from the G protein-coupled Ca2+-mobilizing ATP receptors that are also expressed by mast cells, macrophages, and transformed fibroblasts (156).
On the basis of these unusual functional features and a distinctive nucleotide selectivity and/or pharmacology, these pore-forming ATP receptors have been classified as P2&pe purinergic receptors. ATP receptors with a P2Ztype nucleotide selectivity are also expressed in T-lymphocytes and/or thymocytes (94, 108,112,122,282,290, 384-386)) multipotent hemopoietic stem cells (380)) Friend erythroleukemia cells (65) , and parotid acinar cells (238, 333, 334) . In these latter cell types, ATP and other P2,-receptor agonists elicit a rapid depolarization, Na+ influx, and Ca2+ influx. However, ATP does not signifi-cantly increase the permeability of these cells to larger organic molecules in the >400-Da range. For example, recent fluorescence-activated cell-sorting studies by Wiley and colleagues (personal communication) have indicated that ATP enhances the permeability of human leukemic lymphocytes to ethidium [relative molecular weight (M,) 3141 but not to propidium (M, 414). In contrast, ethidium ion does not readily permeate the ATPinduced pore/channel expressed in parotid cells (334) or murine lymphocytes (282). Thus a variably sized channel or pore appears to be gated when ATP activates P,&ype receptors in different cell types.
Patch-clamp electrophysiological studies in mast cells (349) and macrophages (49) have permitted some characterization of the ion conductance properties of the pores/channels that are induced on agonist occupation of these P2,-receptors. Maximally active concentrations of ATP activate a whole cell conductance in the 35-70 nS range in single rat mast cells (349) and 10 nS in single mouse macrophages (49). In both cell types, this increased conductance can be maximally activated within 40-65 ms after exposure to ATP, and the elevated conductance is immediately reversed on removal of extracellular ATP. Thus it is unlikely that the channel/pore is secondarily regulated by diffusible second messengers or covalent modification.
Single-channel currents that might be associated with these macroscopic ATP-induced whole cell currents could not be resolved in mast cells, but Naumov et al. (250a) have recorded unitary currents in ATP-stimulated rat macrophages. These extracellular ATP-dependent single-channel currents were recorded in cell-attached mode using 0.1 M extracellular Ca2+, Ba2+, SP+, or Mn2+ as the charge carriers. With Ba2+ as the charge carrier, the single-channel currents were characterized by a slope conductance of -11 pS and a reversal potential of about +4O mV. Significantly, similar single-channel currents were observed when outsideout membrane patches were treated with GTPrS. This observation raises the possibility that the ability of ATP to activate these channels may be mediated or modulated by G proteins.
In contrast to the ATP-gated ion channel receptors described previously, the ATP-induced channels in mast cells and macrophages exhibit little selectivity for cations over anions or for monovalent cations over divalent cations. ATP elicits the depolarization of mouse thymocytes even when the cells are incubated in sodium-free medium containing choline or methylglucamine as the major extracellular cations. Isotopic flux studies in human leukemic lymphocytes (384) (385) (386) and in Friend cells (65) also indicate that the Pa,-receptor/pores are permeable to Na+, Li+, Rb+, and Cl-. Agonist occupation of Pz,-receptors is accompanied by enhanced Ca2+ influx and the elevation of cytosolic [Ca2+] in all cell types that express these receptors. In contrast, occupation of P2=receptors does not elicit mobilization of intracellular Ca2+ stores (109, 113, 156, 229) .
Other than these channels/pores, P2&pe receptors have not been associated with the direct activation of other cellular elements (e.g., G proteins, kinases, effector enzymes) normally involved in transmembrane signaling.
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However, we (111) have recently demonstrated that the P2,-receptors expressed in murine macrophages also stimulate a very pronounced increase in PLD activity. Significantly, this PLD activation does not appear to be a secondary response to any of the major cellular parameters (collapse of membrane potential, dissipation of normal ion gradients, elevation of cytosolic [Ca2+]) known to be changed on formation of the ATP-induced pores. Rather, the enhanced PLD activity appears to be absolutely dependent on the formation of ligand-occupied P2zreceptors. It remains to be determined whether this is a common feature of the P2,-receptors expressed in other cell types.
The role of P2&pe receptors in modulating the physiological functions of macrophages, lymphocytes, and mast cells remains unclear. The expression of P2&pe receptors on both macrophages and some lymphocyte subsets has prompted speculation concerning a possible role of such receptors in communication between certain immune effector cells (e.g., killing by CTL) or in macrophage-target cell interaction (336) . It is possible that, during phagocytosis of an antibody-coated target cell, there is release of ATP from the target cell into the limited space between that cell and the phagocytosing macrophage. ATP*-may accumulate to concentrations sufficient to trigger P2,-receptor-mediated activation of pore formation in the macrophage membrane. Although the functional significance of these pores is unknown, one might speculate that they modulate the function of the localized membrane area that is directly involved in formation of the phagosome.
Pharmacological and Biochemical Characterization of Pore-Forming ATP Receptors
Ppz or pore-forming ATP receptors exhibit a very high selectivity for ATP over other adenine and nonadenine nucleotides (65, 156, 282, 302, 338, 385) . ADP, AMP, and all nonadenine nucleotide triphosphates produce no response or only modest reponses even when tested as high concentrations. Synthetic ATP analogues that are modified on adenine or triphosphate moieties (e.g., a,@-methylene ATP) are generally inactive. Although the receptor is highly selective for ATP, it is important to stress that maximal activation of the receptor requires the presence of near-millimolar concentrations of extracellular ATP when target cells are incubated in saline containing physiological concentrations of divalent cations. This contrasts with the ability of ATP, in the micromolar to hundred micromolar range, to maximally activate G proteincoupled ATP receptors or the ATP-gated ion channel receptors, even when cells are incubated in medium containing standard concentrations of extracellular Mg and Ca. However, when divalent cations are removed from the extracellular medium, P2,-receptor effects on ion flux and pore formation can be maximally activated by micromolar levels of ATP (49, 65, 72, 93, 94, 112, 149, 156, 164, 242, 282, 302, 334, 337, 346, 349, 386) . Thus ATP*-, rather than MgATP (or CaATP), is the actual ligand that activates these receptors.
PZz-receptor-mediated pore formation in susceptible cells is a reversible process. After induction, this response can be abruptly terminated by addition of excess extracellular Mg2+ (or Ca2+), which allows resealing of pores and rapid (within seconds) recovery of the membrane potential (94, 146, 147, 156, 252, 349) .
These pores can be reopened by a subsequent addition of excess EDTA to chelate added Mg 2+ This property has provided a tech-. nique for the introduction of small molecules (e.g., GTP@) into cells expressing P2,-purinoceptors without loss of viability (146, 147) .
Several investigators have reported that BzATP, a photoactivatable ATP analogue, is 30-100 times more potent than ATP in activating the P2&ype purinergic receptors expressed in 3T6 fibroblasts (114, 148, 149) , murine macrophages (111, 252), and rat parotid acinar cells (334) . Weisman and colleagues (114,148) have demonstrated that P2,-receptors can be maintained in an irreversibly activated state, even in the absence of nucleotide agonists, after suitable irradiation of BzATPoccupied receptors in intact 3T6 fibroblasts. This suggests that the nucleotide can be covalently associated with activated P2,-receptors and that BzATP might be used to radiolabel protein(s) that constitute these receptors. In contrast, BzATP is not a potent agonist for the G protein-coupled P2&pe (nucleotide) receptors (111, 252)
NA compounds have been identified as specific antagonists of PBz receptors. However, ATP-induced pore formation and depolarization is markedly attenuated in parotid acinar cells (333) that have been pretreated with DIDS, a covalent inhibitor of several transport proteins. It remains to be determined whether DIDS treatment inhibits nucleotide binding to the receptor or blocks permeation through the pore/channel. Amiloride and amiloride analogues can block the ability of ATP to activate Na+ influx, Ca2+ influx, and ethidium uptake in human leukemic lymphocytes (386) .
Expression cloning approaches may prove feasible for the isolation of mRNA and cDNA encoding P2,-type receptors. Nuttle et al. (252) have demonstrated that P2ztype responses can be observed in Xenopus oocytes injected with total mRNA or size-fractionated mRNA derived from murine macrophages. These P2,-receptormediated responses are readily distinguished from the P2,-receptor-mediated responses that are also expressed in oocytes after injection with macrophage mRNA. Beyer and Steinberg (25) have noted that mutant 5774 macrophages, which are deficient in ATP-induced pore formation, also express much lower levels of the connexin43 gap junction protein. It remains to be determined whether gap junction proteins or similar proteins are directly involved in P2z-receptor-mediated pore formation.
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INVITED REVIEW served in ADP-stimulated platelets is a rapid shape change that is shortly followed by aggregation and secretion of the dense granules. The initial ADP-induced shape change has been correlated with a rapid increase in cytosolic [Ca2+] and the phosphorylation of myosin light chain (reviewed in Ref. 75).
More recent studies have focused on characterizing the earliest signal transduction events that are activated by these ADP receptors. ADP induces a transient (-20-s) and multiphasic increase in platelet cytosolic [Ca2+], due to the rapid mobilization of intracellular Ca2+ stores and the rapid influx of extracellular Ca2+ (231, 306, 324, 392) . Rink and colleagues (231, 306) have exploited the small size of platelets to perform stopped-flow measurements of the very early (subsecond) changes in [Ca"+] in fura 2-loaded platelets. These studies have indicated that an initial wave of Ca2+ influx precedes Ca2+ mobilization in ADP-activated platelets. A second wave of Ca2+ influx appears to be activated on release of the intracellular Ca2+ stores (306). These data suggest that activation of a cation channel may be the earliest signaling response that triggered when ADP occupied these receptors. Mahaut-Smith et al. (231, 232) have described patch-clamp experiments that indicate that ADP can rapidly (within 30 ms) activate a whole cell cation conductance and singlechannel currents in human platelets. In addition to Ca2+, this ADP-stimulated channel is permeable to Na+, K+, and Ba2+ Significantly, the initial wave of ADP-induced Ca2+ influx was reported to be similar at 17 and 37°C (306). This suggests that gating of the channel may be directly regulated by ligand binding rather than by the generation of second messengers.
These data are consistent with the possibility that the Pa,-receptor may be a ligand-gated ion channel receptor. However, ADP-treated platelets also exhibit responses that are generally associated with the activation and/or modulation of G protein-regulated effector enzymes. ADP-induced Ca2+ mobilization can be observed even when platelets are suspended in calcium-free medium (306, 392) . This suggests that mobilization must be triggered by mechanisms other than Ca2+-induced Ca2+ release. Inositol phospholipid hydrolysis (216) and Ins-(l,4,5)P3 (85) accumulation are increased in ADPstimulated platelets, but it is unclear whether these phenomena represent the direct activation of a G proteindependent PI-PLC effector. Vickers et al. (366) have indicated that activation of inositol phospholipid hydrolysis in ADP-stimulated platelets may involve the intermediary formation of thromboxane A2 (TxA,), and the subsequent occupation of TxA2 receptors that are known to activate G protein-dependent PI-PLC in platelets and other cells. It also remains to be determined whether G proteins mediate the ability of ADP to 1) attenuate accumulation of CAMP in prostacyclin-stimulated platelets (75) or 2) activate the cation currents characterized by Mahaut-Smith et al. (231, 232) .
Pharmacological and Biochemical Characterization of Platelet ADP Receptors
The pharmacology and ligand-binding properties of platelet ADP receptors have been characterized using a variety of nucleotide analogues and affinity-labeling ap-proaches (20, 75, 121, 155, 185) . Nucleotides that function as effective agonists are limited to ADP and ADP analogues that are substituted at the carbon-2 position of the adenine ring (75, 185); other purine or pyrimidine diphosphates are ineffective. As noted previously, ATP acts as an antagonist of these Pat-purinergic receptors; other nonadenine nucleotide triphosphates can mimic this antagonistic action of ATP (155). Functional studies of ADP-induced Ca2+ transients in platelets have indicated that there is a strong correlation between the abilities of various ADP analogues to both activate aggregation and to increase cytosolic [Ca2+] (160a). Jamieson and colleagues have utilized formaldehydefixed platelets to examine the nucleotide-binding properties of these cells (155, 185) . This mild fixation procedure obviates complications arising from nucleotide catabolism and the secretion of ADP from platelet dense granules. These studies indicated that human platelets express two classes of ADP-binding sites: 1) high-affinity sites that are characterized by & = 30 nM and density of -25,000 sites per platelet and 2) low-affinity sites with a & = 3 PM and a density of ~400,000 sites per cell (155). ATP analogues (and other nucleotide triphosphates) displaced ADP from both bindings sites, albeit with very different Ki values. These investigators also used [36S]-ATPaS to label high-affinity nucleotide binding sites. A single band of 120 kDa was specifically labeled and tentatively identified as the a-chain of GPIIb, a major platelet glycoprotein involved in fibrinogen binding. FSBA has also been used as a nucleotide affinity reagent that can inhibit some ADP-induced responses in platelets and be covalently incorporated into a 100-kDa membrane protein termed aggregin (20, 75, 121) . Based on these observations, Colman (75) has proposed that aggregin per se may constitute a platelet ADP receptor or a component of such a receptor. It remains to be determined whether the GPIIb or aggregin proteins constitute actual components of the functionally defined ADP receptors that behave as ligand-gated channels or, rather, components of the aggregation cascade that are triggered by occupation of these receptors. Recent studies of ADP-induced Ca2+ transients in platelets have indicated that FSBA inhibits aggregation but not ADP-induced increases in [Ca2+] (160a, 286a). This suggests that the effects of ADP on aggregation and cytosolic [Ca2+] can be differentially regulated. Consistent with this possibility is the recent observation that synthetic diacylglycerol analogues potentiate ADP-induced aggregation but inhibit the ADPtriggered increase in Ca2+ (260a).
SUMMARY
There is now widespread agreement that ATP (and other nucleotides) can function as extracellular signaling molecules in diverse biological contexts. There has been very substantial progress in characterizing P2-purinergic receptor-based signal transduction at the cellular and subcellular levels. Given the rapidly evolving technologies for identifying and isolating the genetic elements that encode receptor proteins, the basic molecular architectures of the various P2-purinergic receptors should be defined during the next few years. Delineation of the 5. 
